174 related articles for article (PubMed ID: 27934549)
1. Burden of illness and research investments in translational sciences for pharmaceuticals in metastatic cancers.
Wang WJ; Robertson JC; Basu A
J Comp Eff Res; 2017 Jan; 6(1):15-24. PubMed ID: 27934549
[TBL] [Abstract][Full Text] [Related]
2. Value-engineered translation for regenerative medicine: meeting the needs of health systems.
Bubela T; McCabe C
Stem Cells Dev; 2013 Dec; 22 Suppl 1(Suppl 1):89-93. PubMed ID: 24304083
[TBL] [Abstract][Full Text] [Related]
3. Mission-oriented translational cancer research - health economics.
Jönsson B; Sullivan R
Mol Oncol; 2019 Mar; 13(3):636-647. PubMed ID: 30628161
[TBL] [Abstract][Full Text] [Related]
4. Investments in cancer research awarded to UK institutions and the global burden of cancer 2000-2013: a systematic analysis.
Maruthappu M; Head MG; Zhou CD; Gilbert BJ; El-Harasis MA; Raine R; Fitchett JR; Atun R
BMJ Open; 2017 Apr; 7(4):e013936. PubMed ID: 28428185
[TBL] [Abstract][Full Text] [Related]
5. Financing prevention: opportunities for economic analysis across the translational research cycle.
Crowley DM; Jones D
Transl Behav Med; 2016 Mar; 6(1):145-52. PubMed ID: 27012262
[TBL] [Abstract][Full Text] [Related]
6. Lost in translation: can we afford to miss the trees for the forest?
Hammes SR; Lange CA
Horm Cancer; 2014 Aug; 5(4):203-6. PubMed ID: 24980775
[No Abstract] [Full Text] [Related]
7. The Agenda for Accelerating Pancreatic Research.
Andersen DK; Forsmark CE; Pandol SJ
Pancreas; 2018; 47(10):1177-1179. PubMed ID: 30325854
[No Abstract] [Full Text] [Related]
8. Research Investments in Global Health: A Systematic Analysis of UK Infectious Disease Research Funding and Global Health Metrics, 1997-2013.
Head MG; Fitchett JR; Nageshwaran V; Kumari N; Hayward A; Atun R
EBioMedicine; 2016 Jan; 3():180-190. PubMed ID: 26870829
[TBL] [Abstract][Full Text] [Related]
9. Research investments for UK infectious disease research 1997-2013: A systematic analysis of awards to UK institutions alongside national burden of disease.
Head MG; Brown RJ; Clarke SC
J Infect; 2018 Jan; 76(1):11-19. PubMed ID: 29061335
[TBL] [Abstract][Full Text] [Related]
10. Mapping pneumonia research: A systematic analysis of UK investments and published outputs 1997-2013.
Head MG; Fitchett JR; Newell ML; Scott JA; Harris JN; Clarke SC; Atun R
EBioMedicine; 2015 Sep; 2(9):1193-9. PubMed ID: 26501117
[TBL] [Abstract][Full Text] [Related]
11. CIRM and UKRMP: Different Ways to Invest in Regenerative Medicine.
Weissman IL; Watt FM
Cell Stem Cell; 2016 Jul; 19(1):19-22. PubMed ID: 27392224
[TBL] [Abstract][Full Text] [Related]
12. Are the Norwegian health research investments in line with the disease burden?
Kinge JM; Roxrud I; Vollset SE; Skirbekk V; Røttingen JA
Health Res Policy Syst; 2014 Nov; 12():64. PubMed ID: 25427859
[TBL] [Abstract][Full Text] [Related]
13. Private manufacturers' thresholds to invest in comparative effectiveness trials.
Basu A; Meltzer D
Pharmacoeconomics; 2012 Oct; 30(10):859-68. PubMed ID: 22901018
[TBL] [Abstract][Full Text] [Related]
14. The relationship between government research funding and the cancer burden in South Korea: implications for prioritising health research.
Jung YL; Yoo HS; Kim ES
Health Res Policy Syst; 2019 Dec; 17(1):103. PubMed ID: 31870382
[TBL] [Abstract][Full Text] [Related]
15. Investments in respiratory infectious disease research 1997-2010: a systematic analysis of UK funding.
Head MG; Fitchett JR; Cooke MK; Wurie FB; Hayward AC; Lipman MC; Atun R
BMJ Open; 2014 Mar; 4(3):e004600. PubMed ID: 24670431
[TBL] [Abstract][Full Text] [Related]
16. Translational nanomedicine: status assessment and opportunities.
Murday JS; Siegel RW; Stein J; Wright JF
Nanomedicine; 2009 Sep; 5(3):251-73. PubMed ID: 19540359
[TBL] [Abstract][Full Text] [Related]
17. Bridging the gap between basic science and clinical practice: a role for community clinicians.
Kahn K; Ryan G; Beckett M; Taylor S; Berrebi C; Cho M; Quiter E; Fremont A; Pincus H
Implement Sci; 2011 Apr; 6():34. PubMed ID: 21463516
[TBL] [Abstract][Full Text] [Related]
18. Consensus document on European brain research.
Olesen J; Baker MG; Freund T; di Luca M; Mendlewicz J; Ragan I; Westphal M
J Neurol Neurosurg Psychiatry; 2006 Aug; 77 Suppl 1(Suppl 1):i1-49. PubMed ID: 16845120
[TBL] [Abstract][Full Text] [Related]
19. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
Kelly SP; Anderson WF; Rosenberg PS; Cook MB
Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
[TBL] [Abstract][Full Text] [Related]
20. Developing Common Metrics for the Clinical and Translational Science Awards (CTSAs): Lessons Learned.
Rubio DM; Blank AE; Dozier A; Hites L; Gilliam VA; Hunt J; Rainwater J; Trochim WM
Clin Transl Sci; 2015 Oct; 8(5):451-9. PubMed ID: 26073891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
